This Web site is developed and maintained under the editorial direction of diagnosticimaging.com, the Web site of Diagnostic Imaging magazine and its related publications.
It is the goal of this Web site to be the Web’s most comprehensive and up-to-date source of information on radiofrequency ablation and other energy-based tumor ablation therapies.
Material for this site is developed by physicians and medical journalists. Material also comes from the pages of Diagnostic Imaging magazine and its related publications, from Oncology News International magazine, and from reports published at www.diagnosticimaging.com.
Editorial director:
John C. Hayes, john.hayes@cmpmedica.com
Contributing editors:
Sarah Jersild, sjersild@gmail.com
H.A. Abella, habella@cmp.com
Copy editors:
Kathleen Lawrence
Frances Taylor
Web Master:
DIWebMaster@cmp.comEditorial questions: Inquiries should be directed to the Editor, Diagnostic Imaging, 600 Harrison St., San Francisco, CA 94107, 415/947-6472, john.hayes@cmpmedica.com.
DISCLOSURE: The editorial material on this Web site is published solely by CMP Healthcare Media Group LLC, the publisher of Diagnostic Imaging. CMP Media LLC does not endorse the appropriateness of or are responsible for any actions taken by third parties on the basis of material available at this Web site.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.